Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment

Detalles Bibliográficos
Autores principales: Kampmann, Christoph, Perrin, Amandine, Beck, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941032/
https://www.ncbi.nlm.nih.gov/pubmed/27406229
http://dx.doi.org/10.1186/s13023-016-0482-3
_version_ 1782442237955670016
author Kampmann, Christoph
Perrin, Amandine
Beck, Michael
author_facet Kampmann, Christoph
Perrin, Amandine
Beck, Michael
author_sort Kampmann, Christoph
collection PubMed
description
format Online
Article
Text
id pubmed-4941032
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49410322016-07-13 Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment Kampmann, Christoph Perrin, Amandine Beck, Michael Orphanet J Rare Dis Erratum BioMed Central 2016-07-12 /pmc/articles/PMC4941032/ /pubmed/27406229 http://dx.doi.org/10.1186/s13023-016-0482-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Erratum
Kampmann, Christoph
Perrin, Amandine
Beck, Michael
Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
title Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
title_full Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
title_fullStr Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
title_full_unstemmed Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
title_short Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
title_sort erratum to: effectiveness of agalsidase alfa enzyme replacement in fabry disease: cardiac outcomes after 10 years’ treatment
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941032/
https://www.ncbi.nlm.nih.gov/pubmed/27406229
http://dx.doi.org/10.1186/s13023-016-0482-3
work_keys_str_mv AT kampmannchristoph erratumtoeffectivenessofagalsidasealfaenzymereplacementinfabrydiseasecardiacoutcomesafter10yearstreatment
AT perrinamandine erratumtoeffectivenessofagalsidasealfaenzymereplacementinfabrydiseasecardiacoutcomesafter10yearstreatment
AT beckmichael erratumtoeffectivenessofagalsidasealfaenzymereplacementinfabrydiseasecardiacoutcomesafter10yearstreatment

Ejemplares similares